Allan STRUTHERS

Allan Struthers at at 2nd Human and Veterinary Crosstalk Symposium on Aldosterone, Bordeaux 2011
BSc, MD, FRCP, FESC, FRSE, FMedSci, Professor of Cardiovascular Medicine Division of Medical Sciences University of Dundee, Centre for Cardiovascular & Lung Biology Hospital & Medical School, Dundee, UK.  

Contact: a.d.struthers@dundee.ac.uk

Dr. Allan Struthers graduated MB (Hons) from Glasgow University in 1977. After junior hospital posts in Glasgow, he was Senior Registrar at the Royal Postgraduate Medical School and Hammersmith Hospital in London in 1982-1985. He was then appointed Wellcome Senior Lecturer/Consultant Physician in Dundee and is currently Professor of Cardiovascula rMedicine and runs the Heart Failure service at Ninewells Hospital in Dundee.

He was Chairman of the SIGN Guidelines in Heart Failure (2007) and is now Chairman of NHS-QIS Standards (2010) for Heart Failure. In addition, he is also Chairman of Tenovus NSAC and Senior Regional Advisor for SACDA. Professor Struthers runs a large clinical research programme and has supervised over 40 MD/PhDs. He pioneered the use of plasma BNP to identify heart failure patients and the use of aldosterone blockers to reduce their mortality. Another research interest is in allopurinol and he has recently shown it to have antianginal oxygen sparing effects. He is also using cardiac MRI to assess novel ways to regress left ventricular hypertrophy, e.g. Vitamin D.

He is currently funded (as PI) by the British Heart Fundation, Medical Research Council, CSO,Diabetes (UK) and Chest, Heart & Stroke. In total he has held 30 BHF grants.He has published over 400 papers which are cited around 600 times every year. His research «h» factor is high at 51.